Literature DB >> 30894371

Negative Regulation of p53-Induced Senescence by N-WASP Is Crucial for DMBA/TPA-Induced Skin Tumor Formation.

Hui Li1, Simon Petersen1, Alberto Garcia Mariscal1, Cord Brakebusch2.   

Abstract

Mice with a keratinocyte-restricted deletion of the actin polymerization-promoting molecule, N-WASP, display cyclic hair loss and skin inflammation. Here, we showed that these mice were also resistant to 7,12-dimethylbenz(a)anthracene (DMBA)/12-O-tetradecanoylphorbol-13-acetate (TPA)-induced skin tumor formation. This resistance correlated with decreased expression of the senescence regulator, DNMT1, and increased expression of the senescence marker, p16Ink4a, in N-WASP-deficient epidermis. Moreover, primary N-WASP-null keratinocytes displayed a premature senescence phenotype in vitro. Expression and activation of p53, a major inducer of senescence, was not significantly altered in N-WASP-null keratinocytes. However, impairment of p53 function effectively rescued the senescence phenotype, indicating that N-WASP was an inhibitor of p53-induced senescence. Mechanistically, N-WASP regulated senescence by preventing p53-dependent degradation of the H3K9 methyltransferases, G9a/GLP, and the DNA methyltransferase, DNMT1, which both control keratinocyte senescence. This pathway collaborated with other N-WASP-independent, senescence-promoting signaling downstream of p53 and allowed the fine tuning of p53-induced senescence by N-WASP. Collectively, these data reveal N-WASP as an inhibitor of p53-induced senescence, which might be of importance for skin tumor formation and cellular aging of keratinocytes. SIGNIFICANCE: These findings demonstrate that N-WASP regulates p53-dependent senescence in keratinocytes in vitro and in vivo. ©2019 American Association for Cancer Research.

Entities:  

Year:  2019        PMID: 30894371     DOI: 10.1158/0008-5472.CAN-18-1253

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  6 in total

1.  Loss of Wasl improves pancreatic cancer outcome.

Authors:  Ana Hidalgo-Sastre; Judit Desztics; Zahra Dantes; Katharina Schulte; Hilal Kabadayi Ensarioglu; Blessing Bassey-Archibong; Rupert Öllinger; Thomas Engleiter; Lyndsay Rayner; Henrik Einwächter; Juliet M Daniel; Ali Sameer Abdulghani Altaee; Katia Steiger; Marina Lesina; Roland Rad; Maximilian Reichert; Guido von Figura; Jens T Siveke; Roland M Schmid; Clara Lubeseder-Martellato
Journal:  JCI Insight       Date:  2020-05-21

Review 2.  Rho GTPases in cancer: friend or foe?

Authors:  Julius H Svensmark; Cord Brakebusch
Journal:  Oncogene       Date:  2019-08-19       Impact factor: 9.867

3.  Deficiency of Wiskott-Aldrich syndrome protein has opposing effect on the pro-oncogenic pathway activation in nonmalignant versus malignant lymphocytes.

Authors:  Seong-Su Han; Kuo-Kuang Wen; Yatin M Vyas
Journal:  Oncogene       Date:  2020-11-02       Impact factor: 9.867

4.  Senescence regulation by nuclear N-WASP: a role in cancer?

Authors:  Hui Li; Cord Brakebusch
Journal:  Oncoscience       Date:  2019-08-23

Review 5.  Involvement of Actin and Actin-Binding Proteins in Carcinogenesis.

Authors:  Magdalena Izdebska; Wioletta Zielińska; Marta Hałas-Wiśniewska; Alina Grzanka
Journal:  Cells       Date:  2020-10-06       Impact factor: 6.600

Review 6.  Role of p53 in the Regulation of Cellular Senescence.

Authors:  Mahmut Mijit; Valentina Caracciolo; Antonio Melillo; Fernanda Amicarelli; Antonio Giordano
Journal:  Biomolecules       Date:  2020-03-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.